Loree JM, Dowers A, Tu D, Jonker D, et al. Expanded low allele frequency RAS and BRAF V600E testing in metastatic colorectal cancer as predictive biomarkers for cetuximab in the randomized CO.17 trial. Clin Cancer Res 2020 Oct 21. pii: 1078-0432.CCR-20-2710.
PMID: 33087330